Jieyu Zou - Profile and Investment Details

Investor Profile

Jieyu Zou is a Venture Capital based in Shanghai, China with a diverse investment portfolio that includes companies such as KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical, Metacrine, ImmuneOnco Biopharma, Targeting One, Alector, Hangzhou Just Biotherapeutics (Just China), Fortis Therapeutics, Harpoon Therapeutics, Legend Biotech, Elpiscience Biopharmaceuticals, Ansun BioPharmaGeneseeq, Turning Point Therapeutics, ReadCoor, dMed, Singlera Genomics, Singleron Biotechnologies, IMPACT Therapeutics, Nucleix, RiboX Therapeutics, Geneception, NuVera Medical, CARsgen Therapeutics, Just - Evotec Biologics, Terns Pharmaceuticals, Tmunity Therapeutics, 360 Health, Lilly Asia Ventures 礼来亚洲基金, Transcenta, NextCure, Nuohui Health, Regor Therapeutics, VIRTUE DX, InventisBio, EdiGene, Tempest Therapeutics, Gracell Biotechnologies, Sonoma BioTherapeutics, Peptistar, NiKang Therapeutics, Inhibrx, Rongchang Pharmaceutical, Remegen, Mailing Yiliao, Magnolia NeuroSciences, Burning Rock Biotech, Passage Bio, Fountain Medical Development, CanSinoBIO, MabSpace Biosciences, Sansure Biotech, NovoCodex, Gritstone Oncology, Veritas Genetics, ACEA BIO, Peijia Medical, Insilico Medicine, SynerK, Inc, Jacobio Pharmaceuticals, Avedro, 360 Haoyao, Dizal Pharma, Connect Biopharmaceuticals, Qihan Biotech, Chimagen Biosciences, Ionova Life Science, . Over time, Jieyu Zou has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jieyu Zou is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Genetics, Wellness, Women Founded, Investment Management, Life Science, Engineering, Robotics, Information Technology (IT), Venture Fundraising, Software, Manufacturing, Biotechnology, Genomics, Clinical Trials, Research, Reviews and Recommendations, Health Diagnostics, Medical, B2B, Therapeutics, Media and Entertainment, Personal Health, Pharmaceuticals, Healthcare Technology, Oncology may find it worthwhile to explore potential connections with Jieyu Zou, as their portfolio suggests a familiarity and interest in this area.

Understanding Jieyu Zou’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.